Annual Report to shareholders

Sep 30, 2026 at 1:45 AM EDT · Issued by Clarity Pharmaceuticals Ltd. via ASX

Filed with ASX · Sep 30, 2026 at 1:45 AM EDT

On 6ix: 6ix.com/news/annual-report-to-shareholders-264

CL ARIT Y PHARMACEUTICALS ANNUAL REPORT 20261ABN 36 143 005 341 www.claritypharmaceuticals.com 2026ANNUAL REPORTCL ARIT Y PHARMACEUTICALS ANNUAL REPORT 202612 About Clarity Pharmaceuticals4 Executive Chairperson’s Letter7 CEO’s Letter10 Corporate & Finance12 Clinical & Regulatory Development15...

View Attachment

6ix hasn’t read this filing yet.

Clarity Pharmaceuticals Ltd. on 6ix

Earlier from Clarity Pharmaceuticals

Ceasing to be a substantial holderSep 24
Becoming a substantial holderSep 22
Date of Annual General Meeting 25 November 2026Sep 20
Preliminary Final ReportAug 26
Bioshares Biotech Summit PresentationAug 5

Later from Clarity Pharmaceuticals

Appendix 4GSep 30
Corporate governance statementSep 30
SECuRE updateOct 7
SAR-bisPSMA Presentation - Drug & Device ConferenceOct 12
Notice of Annual General Meeting/Proxy FormOct 22

All Clarity Pharmaceuticals news releases

Follow Clarity Pharmaceuticals into a list and get an email when it puts out news.

Follow Clarity Pharmaceuticals